CYTOTOXICITY TEST OF BOVINE DEMINERALIZED BONE MATRIX ON HUMAN MESENCHYMAL STEM CELLS USING THE MTT ASSAY METHOD
Downloads
The use of bone grafts in Indonesia continues to increase each year. Although Autograft is considered the gold standard in bone grafting, its use is often confronted with various challenges, similar to allograft. To address this issue, Bovine Demineralized Bone Matrix (DBM) can be considered as a substitute for bone grafts with the advantages of unlimited availability and more affordable costs. Currently, the Tissue Bank of Dr. Soetomo Hospital is developing bovine DBM, although there is no research yet on its potential toxicity.This study aims to evaluate whether bovine DBM has cytotoxic effects on human mesenchymal stem cells. In this experimental study, a total of 48 samples were involved, including a control group and two treatment groups (50% and 25%), each consisting of 16 samples. Mesenchymal stem cells were cultured and then treated with the addition of 50% and 25% DBM. Subsequently, cell viability was measured using the MTT Assay method.The collected data were processed by conducting normality and homogeneity tests and then analyzed using comparative tests with an independent t-test. The criteria for declaring cell toxicity were set at a viability of not less than 60% compared to the control group.The results of the MTT assay measurements showed that the mean Optical Density (OD) in the control group was 0.656 ± 0.021 (range 0.620-0.696), while in the treatment groups, it was 0.565 ± 0.022 (range 0.529-0.614) and 0.520 ± 0.022 (range 0.461-0.552), respectively. Statistically, the differences in OD between the control group and both treatment groups (50% and 25%) were significant (p<0.05). The average cell viability in both treatment groups was found to be more than 60%, indicating that Bovine Demineralized Bone Matrix is not toxic to human mesenchymal stem cells.
Werier, J. M. (2013), "Bone Graft Substitutes in Oncology, Paediatrics, and Hip Arthroplasty”, Orthogate.
Winoto, A. R. (2010), "Comparative analysis of mesenchymal stem cells from bone marrow and adipose tissue for osteogenic differentiation”, Majalah Orthopaedi Indonesia, pp. 1-7.
Bigham, A. S., Dehghani, S. N., Shafiei, Z. and Nezhad, S. T. (2008), "Xenogenic demineralized bone matrix and fresh autogenous cortical bone effects on experimental bone healing: radiological, histopathological and biomechanical evaluation”, Journal of Orthopaedics and Traumatology, Vol. 9 No. 2, pp. 73-80.
De Long, W. G., Einhorn, T. A., Koval, K., McKee, M., Smith, W., Sanders, R. and Watson, T. (2007), "Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis”, The Journal of Bone & Joint Surgery, Vol. 89 No. 3, pp. 638-42.
Gruskin, E., Doll, B. A., Futrell, W., Schmitz, J. P. and Hollinger, J. O. (2012), "Demineralized bone matrix in bone repair: history and use”, Advanced Drug Delivery Reviews, Vol. 64 No. 12, pp. 1063-77.
Holt, D. J. and Grainger, D. W. (2012), "Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repair”, Advanced Drug Delivery, Vol. 64 No. 12, pp. 1123-8.
Block, J. E. and Poser, J. (1995), "Does xenogeneic demineralized bone matrix have clinical utility as a bone graft substitute?”, Medical Hypotheses, Vol. 45 No. 1, pp. 27-32.
Rodrigues, M., Griffith, L. G. and Wells A. (2010), "Growth factor regulation of proliferation and survival of multipotential stromal cells”, Stem Cell Research & Therapy, Vol. 1 No. 4, pp. 1-12.
Shi, X., Zhang, Y., Zheng, J. and Pan, J. (2012), "Reactive Oxygen Species in Cancer Stem Cells”, Antioxidants & Redox Signaling, Vol. 16 No. 11, pp. 1215-28.
Copyright (c) 2023 Paulus Ronald Hibono
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without ristrictions.
3. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution (CC BY).
